{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["35(3)"],"submitter":["Khan AH"],"pubmed_abstract":["<h4>Objectives</h4>To observe the efficacy of zinc sulfate on taste alterations in oral cancer patients receiving concurrent chemotherapy with radiotherapy.<h4>Methods</h4>Seventy patients were randomly assigned to both intervention and control group at Oncology Section of Atomic Energy Medical Centre Karachi from September 2017 to March 2018. One group received zinc sulfate capsules (50 mg TDS daily after meals) and the other group received placebo (thrice after meals). Patients were advised to start taking capsules on the first day of their chemoradiation. Both the groups continued the capsules a month after their CCRT ended.<h4>Results</h4>Sweet taste was most effected by cancer and its treatment followed by bitter and salty taste. Sour taste was least effected. When both the groups wer"],"journal":["Pakistan journal of medical sciences"],"pagination":["624-629"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6572971"],"repository":["biostudies-literature"],"pubmed_title":["Efficacy of zinc sulfate on concurrent chemoradiotherapy induced taste alterations in oral cancer patients: A double blind randomized controlled trial."],"pmcid":["PMC6572971"],"pubmed_authors":["Khan AH","Siddiqui SU","Safdar J"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy of zinc sulfate on concurrent chemoradiotherapy induced taste alterations in oral cancer patients: A double blind randomized controlled trial.","description":"<h4>Objectives</h4>To observe the efficacy of zinc sulfate on taste alterations in oral cancer patients receiving concurrent chemotherapy with radiotherapy.<h4>Methods</h4>Seventy patients were randomly assigned to both intervention and control group at Oncology Section of Atomic Energy Medical Centre Karachi from September 2017 to March 2018. One group received zinc sulfate capsules (50 mg TDS daily after meals) and the other group received placebo (thrice after meals). Patients were advised to start taking capsules on the first day of their chemoradiation. Both the groups continued the capsules a month after their CCRT ended.<h4>Results</h4>Sweet taste was most effected by cancer and its treatment followed by bitter and salty taste. Sour taste was least effected. When both the groups wer","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019","modification":"2025-05-29T21:45:21.122Z","creation":"2025-05-29T21:45:21.122Z"},"accession":"S-EPMC6572971","cross_references":{"pubmed":["31258565"],"doi":["10.12669/pjms.35.3.503"]}}